Institutional investors purchased a net $3.6 million shares of OVID during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 59.17% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 2.4 Million shares of Ovid Therapeutics Inc
SSGA FUNDS MANAGEMENT, INC. Bought 834.9 Thousand shares of Ovid Therapeutics Inc
GEODE CAPITAL MANAGEMENT LLC Bought 713.5 Thousand shares of Ovid Therapeutics Inc